Research Overview: NOLVAMED 20 DEUS MEDICAL
NOLVAMED 20 DEUS MEDICAL is a selective estrogen receptor modulator (SERM) containing tamoxifen citrate, specifically manufactured for in-vitro laboratory research applications. This pharmaceutical-grade compound represents a cornerstone research tool for investigating estrogen receptor interactions and cellular mechanisms. Each tablet contains precisely 20mg of tamoxifen citrate, ensuring consistent research parameters across experimental protocols. The compound’s unique molecular structure allows researchers to examine selective estrogen receptor binding patterns and downstream signalling pathways in controlled laboratory environments.
As a leading UK supplier, Stroid UK Shop provides this research compound alongside comprehensive analytical documentation. Researchers investigating hormonal pathways often examine this SERM in conjunction with other compounds available in our estrogen blockers collection. The pharmaceutical manufacturing standards ensure optimal stability and purity for extended research protocols requiring consistent compound integrity.
Laboratory Research Applications
Research scientists utilise NOLVAMED 20 to investigate estrogen receptor modulation mechanisms across various cellular systems. The compound’s selective binding properties enable researchers to examine tissue-specific estrogen responses and receptor subtype interactions. Laboratory studies frequently examine this SERM’s influence on gene expression patterns, particularly those regulated by estrogen response elements. Comparative research protocols often investigate this compound alongside other research chemicals from our SARMs collection to examine receptor selectivity differences.
Advanced research applications include examining the compound’s interactions with co-activator and co-repressor proteins in cell culture systems. Researchers studying hormonal signalling pathways analyse how this SERM modulates transcriptional activity in different tissue contexts. The compound’s metabolite profile provides additional research opportunities, particularly when investigating cytochrome P450 enzyme interactions. Many laboratories combine these investigations with compounds from our peptides range for comprehensive hormonal research protocols.
Compound Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Tamoxifen Citrate |
| Concentration | 20mg per tablet |
| Presentation | Oral tablets |
| CAS Number | 54965-24-1 |
| Molecular Formula | C32H37NO8 |
| Molecular Weight | 563.64 g/mol |
| Storage Conditions | Room temperature, dry conditions |
Research Compliance Statement
NOLVAMED 20 DEUS MEDICAL is manufactured exclusively for in-vitro research applications and laboratory studies. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with relevant institutional guidelines and local regulations governing research chemical handling and storage.
